Big pharma, M&A, Pharma

Valeant extends the acquisition of Allergan

Posted on 19 August 2014

Tags: , ,

Valeant Pharmaceuticals has extended the acquisition period for Allergan.

 Valeant Pharmaceuticals International has extended the expiration of its exchange offer to acquire all of the outstanding shares of Allergan to 5:00 p.m.New York City time, on December 31, 2014.

The exchange offer was previously scheduled to expire at 5:00 p.m.New York City time today, Friday, August 15, 2014.

All other terms and conditions of the exchange offer remain unchanged.

The depositary of the exchange offer has advised that, as of 9:00 a.m.New York City time, on August 15, 2014, a total of approximately 12,509,606 shares of Allergan common stock were validly tendered and not properly withdrawn in the exchange offer.

For further deal information visit Current Agreements (subscription required)

Related

Read: more on M&A deals in pharma, biotech, life science partnering deal news, insights and glossary

Report : Partnering Agreements with Valeant 2009-2014

Report: Pharma and Biotech M&A Trends 2009-2014

Browse: Complete Current Partnering report catalog

View: Current Partnering’s M&A Scorecard – view top life science partnering deals by value

View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making

View: Current Partnering’s Big Pharma Partnering activity – latest trends in big pharma deal making activity

View: Current Partnering’s Big Biotech Parnering activity – latest trends in big biotech deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter – reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Follow us on: LinkedIn Current Partnering | LinkedIn Business Development Network | @Currentpartner on Twitter

Print Friendly, PDF & Email

Leave a Reply